|
Diagnosis
|
Number
|
Percentage of positive cell (mean ± SD)
|
Incidence of positive cases (number positive/total number)
|
|---|
|
Control group
|
40
|
2.4 ± 1.2
|
0 (0.0)
|
|
Study group
|
151
| | |
|
CIN I
|
27
|
9.2 ± 4.6*
|
44.4% (12 /27)*
|
|
CIN II/III
|
54
|
16.0 ± 14.4*
|
85.1% (46/54)*
|
|
Carcinoma in situ
|
17
|
19.7 ± 13.3*
|
88.3% (15 /17)*
|
|
Invasive Carcinoma
|
28
|
47.0 ± 25.2 *
|
100% (28 /28)*
|
|
CIN LEEP post-treatment
|
11
|
7.2 ± 2.7*
|
18.2% (2 /11)
|
|
Cervical cancer post-treatment
|
14
|
7.1 ± 2.0*
|
14.3% (2 /14)
|
- FISH, fluorescence in situ hybridization; hTERC, human telomerase mRNA component gene; Number, number of cases; CIN, cervical intraepithelial neoplasia; LEEP, loop electrical excision procedure. *P < 0.05 (compared with the control group).
